Arbutus Biopharma (ABUS) Interest Coverage Ratio (2017 - 2025)
Historic Interest Coverage Ratio for Arbutus Biopharma (ABUS) over the last 9 years, with Q3 2025 value amounting to 376.48.
- Arbutus Biopharma's Interest Coverage Ratio rose 4907.71% to 376.48 in Q3 2025 from the same period last year, while for Sep 2025 it was 429.39, marking a year-over-year increase of 2200.79%. This contributed to the annual value of 557.07 for FY2024, which is 22738.37% down from last year.
- Per Arbutus Biopharma's latest filing, its Interest Coverage Ratio stood at 376.48 for Q3 2025, which was up 4907.71% from 53.14 recorded in Q2 2025.
- In the past 5 years, Arbutus Biopharma's Interest Coverage Ratio registered a high of 53.14 during Q2 2025, and its lowest value of 917.82 during Q1 2025.
- In the last 5 years, Arbutus Biopharma's Interest Coverage Ratio had a median value of 87.94 in 2023 and averaged 259.31.
- As far as peak fluctuations go, Arbutus Biopharma's Interest Coverage Ratio crashed by 102880.68% in 2023, and later skyrocketed by 10837.17% in 2025.
- Quarter analysis of 5 years shows Arbutus Biopharma's Interest Coverage Ratio stood at 37.14 in 2021, then crashed by 96.62% to 73.02 in 2022, then plummeted by 545.78% to 471.52 in 2023, then grew by 1.5% to 464.43 in 2024, then grew by 18.94% to 376.48 in 2025.
- Its Interest Coverage Ratio stands at 376.48 for Q3 2025, versus 53.14 for Q2 2025 and 917.82 for Q1 2025.